Colorectal Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Diagnosis Type (Diagnostics Imaging (Sigmoidoscopy, Colonoscopy, Others), Stool Test (Guaiac FOBT, Fecal immunochemical Test (FIT), FIT-DNA Test), Biopsy (Image Guided Biopsy, Liquid Biopsy, Others), Others), By Application (Hospitals & Specialty Clinics, Ambulatory Care Centers, and Others, By Region, by competition

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

Global Colorectal Cancer Diagnostics Market is anticipated to witness a steady CAGR in the forecast period, 2024-2028. According to Global Cancer Observatory, in 2020, around 1,931,590 new colorectal cancer cases were reported worldwide among which the males and females accounted for 1,065,960 and 8,65,630 cases respectively in 2020. Colorectal cancer is caused due to uncontrolled proliferation of cancer cells that starts from the inner linings of the colon and rectum. This uncontrolled growth is commonly referred to as ‘polyps’. The demand for new diagnostics techniques/tools is increasing, which is further expected to drive the growth of Global Colorectal Cancer Diagnostics Market. 

The growing prevalence of colorectal cancer, the advanced technological advancement with highest accuracy and precision, and the growing awareness amongst population globally are projected to propel the growth of market. Additionally, expansion in research & development schemes being initiated by various government institutions, private institutions and diagnostics imaging centers across the globe is further expected to create lucrative opportunities for the growth of Global Colorectal Cancer Diagnostics Market in the coming years. According to Statista Research Department, the estimated number of colorectal cancer cases among men and women in the United States in 2022 were around 117,910 and 1,18,830, respectively.

Increasing Incidence of Colorectal Cancer

Increasing incidence of colon and rectal cancer is acting as a burden on the society. The medical professionals are increasing their research and development activities to develop advanced treatments and diagnostic services to aid prevention and treatment of cancer. This in turn is expected to fuel the growth of the market during the forecast period. According to the American Cancer Society, colorectal cancer is the third most common form of cancer in men as compared to women, after skin cancer. Further, as per American Cancer Society 2022, the number of cases is increasing around 106,180 new cases of colon cancer and 44,850 new cases of rectal cancer in United States. Therefore, rise in treatment and advanced Diagnostics procedures are propelling the growth of the Colorectal Cancer Diagnostics Market   throughout the forecast period.

 

Download Free Sample Report

Sedentary Lifestyle and rising awareness among individuals

The main cause of colorectal cancer unhealthy lifestyle and consumption of unhealthy food. According to the Centers for Disease Control and Prevention (CDC), around 15% adults are physically inactive, and do not participate in activities such as running, walking for exercise, or gardening. Moreover, ageing population and growing public awareness in terms of government policies and advanced treatments is anticipated to support the growth of the market. As the government attempts to offer better and more inexpensive treatments along with beneficial reimbursement policies. Additionally, rising consumer acceptance of advanced therapies such as Stivarga (regorafenib), Erbitux (cetuximab), and Avastin (bevacizumab) is estimated to support the growth of the market.


Growth in Research & Development

Rapid advancements in research and development (R&D) practices and activities are propelling the growth of the market due to growing need fordeveloping novel diagnostic solutions for the treatment of different life-threatening diseases like colorectal cancer. According to Clinicaltrials.gov, 5213 clinical trials are in different phases of development across the globe for colorectal cancer. A recent advancement includes colorectal cancer treatment with immunotherapy that is anticipated to be significant due to high availability of immunotherapy drugs. Moreover, several initiatives have been taken by the government and non-government organizations for making diagnostics procedures affordable, thereby supporting the growth of global colorectal cancer diagnostics market.

 

Market Segmentation

Global Colorectal Cancer Diagnostics Market can be segmented by diagnosis type, application, region and company. Based on diagnosis type, the market can be segmented into diagnostics imaging, stool test, biopsy, and others. Based on diagnostics imaging, the market is fragmented into sigmoidoscopy, colonoscopy, and others. Based on stool test, the market is fragmented into Guaiac FOBT, FIT, FIT-DNA Test. Based on biopsy, the market is fragmented into Image Guided Biopsy, Liquid Biopsy, and others. Based on application, the market is segmented into hospitals & specialty clinics, ambulatory care centers, and others.

 

Advancement in Technology and Product Launches

The market players in global colorectal cancer diagnostics market are adopting various natural and modified strategies for market growth and development. For instance, in January 2022, Clinical Genomics, a leading innovator of colorectal cancer testing, and Quest Diagnostics (NYSE: DGX), the global leader in Diagnostics information services, announced a 5-year extension of their US supply agreement for the InSure ONE (FIT) fecal immunochemistry test. This agreement builds on a long-standing collaboration to provide InSure FIT and the new InSure ONE FIT for colorectal cancer diagnostics programs. In February 2022, Amgen and Plexium announced a multi-year collaboration to identify novel targeted protein degradation therapies. The multi-year collaboration supports the discovery of novel molecular glue therapeutics leveraging insights from Amgen's expertise in developing multi-specific molecules. Furthermore, several strategies like collaboration, partnerships, mergers, acquisitions, product launches, and technology development propell the growth of global colorectal cancer diagnostics market.

 

Company Profiles

Abbott Laboratories, Illumina, Inc., Sysmex Corporation, Beckman Coulter, Siemens Healthineers AG, Quest Diagnostics, Danaher Corporation, Cancer Genetics Inc, Biocept Inc., Epigenomics AG, etc. are some of the key players operating in the global colorectal cancer diagnostics market.

Attribute

Details

Base Year

2022

Historic Data

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

Diagnosis Type

Application

Region

Company

Regional scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country scope

United States; Canada; Mexico; Germany; France; United Kingdom; Spain; Italy; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; UAE; Saudi Arabia; Africa; Turkey; Egypt

Key companies profiled

Abbott Laboratories, Illumina, Inc., Sysmex Corporation, Beckman Coulter, Siemens Healthineers AG, Quest Diagnostics, Danaher Corporation, Cancer Genetics Inc, Biocept Inc., Epigenomics A.G.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 Report Scope:

In this report, Global Colorectal Cancer Diagnostics Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Colorectal Cancer Diagnostics Market, By Diagnosis Type:
    • Diagnostics Imaging
      • Sigmoidoscopy
      • Colonoscopy
      • Others
    • Stool Test
      • Guaiac FOBT
      • Fecal immunochemical Test (FIT)
      • FIT-DNA Test
    • Biopsy
      • Image Guided Biopsy
      • Liquid Biopsy
      • Others
    • Others
  • Colorectal Cancer Diagnostics Market, By Application:

o   Hospitals & Specialty Clinics

o   Ambulatory Care Centers

o   Others             

  • Colorectal Cancer Diagnostics Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • UAE
      • Saudi Arabia
      • South Africa
      • Turkey
      • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Colorectal Cancer Diagnostics Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Colorectal Cancer Diagnostics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Service Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Colorectal Cancer Diagnostics Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Diagnosis Type (Diagnostics Imaging, Stool Test, Biopsy, Others)

5.2.1.1. By Diagnostics Imaging (Sigmoidoscopy, Colonoscopy, and Others)

5.2.1.2. By Stool Test (Guaiac FOBT, Fecal immunochemical (or immunohistochemical) Test (FIT), FIT-DNA Test)

5.2.1.3. By Biopsy (Image Guided Biopsy, Liquid Biopsy, Others)

5.2.2.     By Application (Hospitals & Specialty Clinics, Ambulatory Care Centers, and Others)

5.2.3.     By Region (North America, Europe, Asia Pacific, South America, Middle-East and Africa)

5.2.4.     By Company (2022)

5.3.  Market Map

5.3.1.     By Test Type

5.3.2.     By Application

5.3.3.     By Region

6.    North America Colorectal Cancer Diagnostics Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Test Type

6.2.2.     By Application

6.2.3.     By Country

6.3.  North America: Country Analysis

6.3.1.     United States Colorectal Cancer Diagnostics Market Outlook

6.3.1.1.         Market Size & Forecast

6.3.1.1.1.             By Value

6.3.1.2.         Market Share & Forecast

6.3.1.2.1.             By Test Type

6.3.1.2.2.             By Application

6.3.2.     Canada Colorectal Cancer Diagnostics Market Outlook

6.3.2.1.         Market Size & Forecast

6.3.2.1.1.             By Value

6.3.2.2.         Market Share & Forecast

6.3.2.2.1.             By Test Type

6.3.2.2.2.             By Application

6.3.3.     Mexico Colorectal Cancer Diagnostics Market Outlook

6.3.3.1.         Market Size & Forecast

6.3.3.1.1.             By Value

6.3.3.2.         Market Share & Forecast

6.3.3.2.1.             By Test Type

6.3.3.2.2.             By Application

7.    Europe Colorectal Cancer Diagnostics Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.1.1.             By Test Type

7.2.1.1.2.             By Application

7.2.1.1.3.             By Country

7.3.  Europe: Country Analysis

7.3.1.     Germany Colorectal Cancer Diagnostics Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Test Type

7.3.1.2.2.             By Application

7.3.2.     France Colorectal Cancer Diagnostics Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Test Type

7.3.2.2.2.             By Application

7.3.3.     United Kingdom Colorectal Cancer Diagnostics Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Test Type

7.3.3.2.2.             By Application

7.3.4.     Italy Colorectal Cancer Diagnostics Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Test Type

7.3.4.2.2.             By Application

7.3.5.     Spain Colorectal Cancer Diagnostics Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Test Type

7.3.5.2.2.             By Application

8.    Asia-Pacific Colorectal Cancer Diagnostics Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.1.1.             By Test Type

8.2.1.1.2.             By Application

8.2.1.1.3.             By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.     China Colorectal Cancer Diagnostics Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Test Type

8.3.1.2.2.             By Application

8.3.2.     Japan Colorectal Cancer Diagnostics Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Test Type

8.3.2.2.2.             By Application

8.3.3.     India Colorectal Cancer Diagnostics Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Test Type

8.3.3.2.2.             By Application

8.3.4.     South Korea Colorectal Cancer Diagnostics Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Test Type

8.3.4.2.2.             By Application

8.3.5.     Australia Colorectal Cancer Diagnostics Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Test Type

8.3.5.2.2.             By Application

9.    South America Colorectal Cancer Diagnostics Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.1.1.             By Test Type

9.2.1.1.2.             By Application

9.2.1.1.3.             By Country

9.3.  South America: Country Analysis

9.3.1.     Brazil Colorectal Cancer Diagnostics Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Test Type

9.3.1.2.2.             By Application

9.3.2.     Argentina Colorectal Cancer Diagnostics Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Test Type

9.3.2.2.2.             By Application

9.3.3.     Colombia Colorectal Cancer Diagnostics Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Test Type

9.3.3.2.2.             By Application

10.  Middle East and Africa Colorectal Cancer Diagnostics Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Test Type

10.2.2.  By Application

10.2.3.  By Country

10.3.              MEA: Country Analysis

10.3.1.  UAE Colorectal Cancer Diagnostics Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.             By Test Type

10.3.1.2.2.             By Application

10.3.2.  Saudi Arabia Colorectal Cancer Diagnostics Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.             By Test Type

10.3.2.2.2.             By Application

10.3.3.  South Africa Colorectal Cancer Diagnostics Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.             By Test Type

10.3.3.2.1.1.               By Application

10.3.4.  Turkey Colorectal Cancer Diagnostics Market Outlook

10.3.4.1.      Market Size & Forecast

10.3.4.1.1.           By Value

10.3.4.2.      Market Share & Forecast

10.3.4.2.1.             By Test Type

10.3.4.2.2.             By Application

10.3.5.  Egypt Colorectal Cancer Diagnostics Market Outlook

10.3.5.1.      Market Size & Forecast

10.3.5.1.1.           By Value

10.3.5.2.      Market Share & Forecast

10.3.5.2.1.             By Test Type

10.3.5.2.2.             By Application

11.  Market Dynamics

11.1.              Drivers

11.1.1.  Increasing Incidence of Colorectal Cancer

11.1.2.  Sedative Lifestyle

11.1.3.  Growth in Research & Development

11.2.              Challenges

12.  Market Trends & Developments

13.  Clinical Trial Analysis

13.1.              Ongoing Clinical Trials

13.2.              Completed Clinical Trials

13.3.              Terminated Clinical Trials

13.4.              Breakdown of Pipeline, By Development Phase

13.5.              Breakdown of Pipeline, By Status

13.6.              Breakdown of Pipeline, By Study Application

13.7.              Breakdown of Pipeline, By Region

13.8.              Clinical Trials Heat Map

14.  Competitive Landscape

14.1.              Business Overview

14.2.              Product Offerings

14.3.              Recent Developments

14.4.              Financials (In Case of Listed Companies)

14.5.              Key Personnel

14.6.              SWOT Analysis

14.6.1.                Abbott Laboratories

14.6.2.                Illumina, Inc.

14.6.3.                Sysmex Corporation

14.6.4.                Beckman Coulter

14.6.5.                Siemens Healthineers AG

14.6.6.                Quest Diagnostics

14.6.7.                Danaher Corporation

14.6.8.                Cancer Genetics Inc.

14.6.9.                Biocept Inc.

14.6.10.             Epigenomics AG

15.  Strategic Recommendations

16. About Us and Disclaimer

Figures and Tables

Frequently asked questions

down-arrow

Global Colorectal Cancer Diagnostics Market is expected to grow at an impressive rate on account of increasing prevalence of this type of cancer and growing research & development for the development of modified imaging solutions.

down-arrow

United States will be the fastest growing country in North America region due to sedentary lifestyle and poor eating & dietary habits which are prevalent in the nation.

down-arrow

Abbott Laboratories, Illumina, Inc., Sysmex Corporation, Beckman Coulter, Siemens Healthineers AG, Quest Diagnostics, Danaher Corporation, Cancer Genetics Inc, Biocept Inc., Epigenomics A.G. among others are some of the leading players operating in the global colorectal cancer diagnostics market.

down-arrow

Guaiac FOBT tests for colorectal cancer diagnosis is anticipated to be widely adopted over the next ten years.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Colorectal Cancer Diagnostics Market to be dominated by Diagnostic Imaging through 2028

Jan, 2023

Advancement diagnostic procedures and rising awareness among individuals is expected to drive the growth of Global Colorectal Cancer Diagnostics Market during the forecast period.

Why Choose Us